Brief: Point Biopharma Unveils Frontier A Pan-Cancer Fap-Α Targeted Clinical Program
May 16 (Reuters) - POINT Biopharma Global Inc PNT.O :
* POINT BIOPHARMA UNVEILS FRONTIER: A PAN-CANCER FAP-Α
TARGETED
CLINICAL PROGRAM
Source text for Eikon: ID:nGNX4yGS6S
Further company coverage: PNT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on POINT Biopharma Global
See all newsBrief: Eli Lilly Completes Acquisition Of POINT Biopharma
Fusion Pharma gains on Bristol Myers-RayzeBio deal
Brief: Point Biopharma- Lilly Offer Expired And Not Further Extended - SEC Filing
Brief: BVF Partners Dissolves Share Stake In Point Biopharma Global
U.S. STOCKS ON THE MOVE-Biomerica, Netflix, SunPower